TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 141, Issue 8, Pages 1630-1642
Publisher
Wiley
Online
2017-07-03
DOI
10.1002/ijc.30862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term administration of bisphosphonate to reduce local recurrence of sacral giant cell tumor after nerve-sparing surgery
- (2017) Wei Xu et al. JOURNAL OF NEUROSURGERY-SPINE
- Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair
- (2016) Nobutaka Sato et al. BONE
- Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India
- (2016) Bharat Rekhi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial
- (2015) T. Ueda et al. ANNALS OF ONCOLOGY
- Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio
- (2015) Kukiat Tudpor et al. BONE
- Osteoblast-derived microvesicles: A novel mechanism for communication between osteoblasts and osteoclasts
- (2015) Lili Deng et al. BONE
- Treatment and outcome of primary aggressive giant cell tumor in the spine
- (2015) Huabin Yin et al. EUROPEAN SPINE JOURNAL
- Endothelial cell protein C receptor promotes MGC803 gastric cancer cells proliferation and migration by activating ERK1/2
- (2015) Qingling Wang et al. MEDICAL ONCOLOGY
- MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone
- (2015) Ting Wang et al. Oncotarget
- Prohibitin is involved in the activated internalization and degradation of protease-activated receptor 1
- (2014) Yan-Jie Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP
- (2014) Wang Zhou et al. BONE
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- Prognostic value of matrix metalloprotease-1/protease-activated receptor-1 axis in patients with prostate cancer
- (2014) Jian Wang et al. MEDICAL ONCOLOGY
- Subchondral bone influences chondrogenic differentiation and collagen production of human bone marrow-derived mesenchymal stem cells and articular chondrocytes
- (2014) Michaela Leyh et al. ARTHRITIS RESEARCH & THERAPY
- A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure
- (2013) A. Aronovich et al. BLOOD
- Loss of SMAD4 From Colorectal Cancer Cells Promotes CCL15 Expression to Recruit CCR1+ Myeloid Cells and Facilitate Liver Metastasis
- (2013) Yoshiro Itatani et al. GASTROENTEROLOGY
- Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor
- (2013) C.-H. Yeh et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC
- (2013) Faik Güntac Uzunoglu et al. LUNG CANCER
- Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone
- (2013) Zhiyuan Lou et al. MEDICAL ONCOLOGY
- Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis
- (2013) Nicolas Malaquin et al. PLoS One
- Factors Affecting Prognosis of Patients with Giant Cell Tumors of the Mobile Spine: Retrospective Analysis of 102 Patients in a Single Center
- (2012) Wei Xu et al. ANNALS OF SURGICAL ONCOLOGY
- Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model
- (2012) Junjing Jia et al. BONE
- Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
- (2012) D. G. Branstetter et al. CLINICAL CANCER RESEARCH
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- A short-term in vivo model for giant cell tumor of bone
- (2011) Maurice Balke et al. BMC CANCER
- Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma Microenvironment
- (2011) Stefanie Krenzer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion
- (2010) Daisuke Fujimoto et al. BMC CANCER
- Transforming Growth Factor-β Coordinately Induces Suppressor of Cytokine Signaling 3 and Leukemia Inhibitory Factor to Suppress Osteoclast Apoptosis
- (2010) Ming Ruan et al. ENDOCRINOLOGY
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- Cathepsin G Recruits Osteoclast Precursors via Proteolytic Activation of Protease-Activated Receptor-1
- (2009) T. J. Wilson et al. CANCER RESEARCH
- Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis
- (2009) Xiaotun Zhang et al. PROSTATE
- TGF-β coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival
- (2008) Anne Gingery et al. EXPERIMENTAL CELL RESEARCH
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More